NO151500C - Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater

Info

Publication number
NO151500C
NO151500C NO792139A NO792139A NO151500C NO 151500 C NO151500 C NO 151500C NO 792139 A NO792139 A NO 792139A NO 792139 A NO792139 A NO 792139A NO 151500 C NO151500 C NO 151500C
Authority
NO
Norway
Prior art keywords
tiazoloxic
preparation
acid derivatives
therapeutically active
analogy procedure
Prior art date
Application number
NO792139A
Other languages
English (en)
Norwegian (no)
Other versions
NO792139L (no
NO151500B (no
Inventor
Friedrich Karl Hess
Patrick Brian Stewart
James Thomas Oliver
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO792139L publication Critical patent/NO792139L/no
Publication of NO151500B publication Critical patent/NO151500B/no
Publication of NO151500C publication Critical patent/NO151500C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO792139A 1978-06-27 1979-06-26 Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater NO151500C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782828091 DE2828091A1 (de) 1978-06-27 1978-06-27 4-substituierte thiazoloxamsaeuren sowie ihre salze und ester

Publications (3)

Publication Number Publication Date
NO792139L NO792139L (no) 1979-12-28
NO151500B NO151500B (no) 1985-01-07
NO151500C true NO151500C (no) 1985-04-24

Family

ID=6042852

Family Applications (1)

Application Number Title Priority Date Filing Date
NO792139A NO151500C (no) 1978-06-27 1979-06-26 Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater

Country Status (36)

Country Link
US (1) US4238496A (fr)
JP (1) JPS557290A (fr)
AT (1) AT373884B (fr)
AU (1) AU525312B2 (fr)
BE (1) BE877293A (fr)
BG (1) BG30324A3 (fr)
CA (1) CA1246071A (fr)
CH (1) CH644370A5 (fr)
CS (1) CS208114B2 (fr)
DD (1) DD144542A5 (fr)
DE (1) DE2828091A1 (fr)
DK (1) DK147940C (fr)
ES (1) ES481917A1 (fr)
FI (1) FI69456C (fr)
FR (1) FR2429787A1 (fr)
GB (1) GB2023580B (fr)
GR (1) GR69231B (fr)
HK (1) HK66285A (fr)
HU (1) HU178996B (fr)
IE (1) IE48357B1 (fr)
IL (1) IL57659A0 (fr)
IT (1) IT1120443B (fr)
LU (1) LU81424A1 (fr)
MY (1) MY8600653A (fr)
NL (1) NL7904957A (fr)
NO (1) NO151500C (fr)
NZ (1) NZ190842A (fr)
PH (1) PH17226A (fr)
PL (1) PL117333B1 (fr)
PT (1) PT69822A (fr)
RO (1) RO77553A (fr)
SE (1) SE446182B (fr)
SG (1) SG61985G (fr)
SU (1) SU791237A3 (fr)
YU (1) YU41645B (fr)
ZA (1) ZA793176B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321372A (en) * 1980-06-16 1982-03-23 Pfizer Inc. Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
DE3027528A1 (de) * 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Ueberbrueckte thiazolyloxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
DE3027527A1 (de) 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Neue oxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
FR2494272A1 (fr) * 1980-11-19 1982-05-21 Fabre Sa Pierre Derives de l'acide thiazolyl-2 oxamique substitues en position 4 par un radical thienyle ou furyle, leur preparation et leur utilisation comme medicaments
DE3135250A1 (de) * 1981-09-05 1983-03-17 Basf Ag, 6700 Ludwigshafen Tricyclische thiazolyloxamate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
US4788198A (en) * 1983-09-01 1988-11-29 Boehringer Ingelheim Pharmaceuticals, Inc. Diazine-ethyenylphenyl oxamic acids and esters and salts thereof
ATE38224T1 (de) * 1983-09-01 1988-11-15 Boehringer Ingelheim Ltd Diazin-ethenylphenyloxamidsaeuren und deren ester und salze.
US4681884A (en) * 1983-09-01 1987-07-21 Boehringer Ingelheim Pharmaceuticals, Inc. Diazine-ethenylphenyl oxamic acids and esters and salts thereof
IT1204959B (it) * 1987-03-25 1989-03-10 Zambon Farmaceutici Spa Composti dotati di attivita' antiallergica
IT1204960B (it) * 1987-03-25 1989-03-10 Zambon Farmaceutici Spa Composti dotati di attivita' antiallergica
DE3807232A1 (de) * 1988-03-05 1989-09-14 Bayer Ag Substituierte acrylsaeureester
JPH0667836B2 (ja) * 1989-03-01 1994-08-31 東洋紡績株式会社 アミド系化合物からなる抗アレルギー剤
FR2671552B1 (fr) * 1991-01-15 1993-05-07 Pf Medicament Procede de preparation de thiazolyl-2 oxamates d'alkyle.
DE69821132T2 (de) * 1997-10-27 2004-10-21 Takeda Chemical Industries Ltd 1,3-thiazole als adenosine a3 rezeptor antagonisten zur behandlung von asthma, allergien und diabetes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1062245B (de) * 1957-10-17 1959-07-30 Ciba Geigy Verfahren zur Herstellung von 2-Amino-4-pyridyl-(2')-thiazol und seinen Salzen
FR1526074A (fr) * 1967-03-22 1968-05-24 Rech S Ind S O R I Soc D Méthoxy-phényl-amino-2-thiazoles, leurs amides et leurs procédés de préparation
BE795907A (fr) * 1972-02-25 1973-06-18 Luso Farmaco Inst 2-amino-4-arylthiazoles 5-substitues et leur preparation
US3966965A (en) * 1973-03-23 1976-06-29 American Home Products Corporation Oxamic acid derivatives for the prevention of immediate type hypersensitivity reactions
US4054666A (en) * 1973-03-23 1977-10-18 American Home Products Corporation Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives
FR2429210A1 (fr) * 1978-06-19 1980-01-18 Fabre Sa Pierre Derives de phenyl-4 thiazolyl-2 oxamates utiles dans le traitement de l'asthme

Also Published As

Publication number Publication date
CA1246071A (fr) 1988-12-06
GB2023580B (en) 1982-08-25
YU149779A (en) 1982-10-31
FR2429787A1 (fr) 1980-01-25
CS208114B2 (en) 1981-08-31
BE877293A (fr) 1979-12-27
HU178996B (en) 1982-07-28
IE48357B1 (en) 1984-12-26
PH17226A (en) 1984-07-03
DK147940C (da) 1985-09-02
PL117333B1 (en) 1981-07-31
IL57659A0 (en) 1979-10-31
SG61985G (en) 1986-05-02
DE2828091C2 (fr) 1988-05-26
IT7949533A0 (it) 1979-06-25
PT69822A (de) 1979-07-01
ZA793176B (en) 1981-03-25
GB2023580A (en) 1980-01-03
US4238496A (en) 1980-12-09
AU525312B2 (en) 1982-10-28
BG30324A3 (en) 1981-05-15
NO792139L (no) 1979-12-28
JPS557290A (en) 1980-01-19
SU791237A3 (ru) 1980-12-23
FI69456C (fi) 1986-02-10
LU81424A1 (de) 1980-07-21
JPS6356225B2 (fr) 1988-11-07
DK269879A (da) 1979-12-28
RO77553A (fr) 1982-02-01
HK66285A (en) 1985-09-13
SE446182B (sv) 1986-08-18
DE2828091A1 (de) 1980-01-10
NL7904957A (nl) 1980-01-02
FR2429787B1 (fr) 1982-12-31
NZ190842A (en) 1981-01-23
AU4839779A (en) 1980-01-03
DK147940B (da) 1985-01-14
NO151500B (no) 1985-01-07
ATA431879A (de) 1983-07-15
IE791200L (en) 1979-12-27
CH644370A5 (de) 1984-07-31
MY8600653A (en) 1986-12-31
PL216608A1 (fr) 1980-03-24
YU41645B (en) 1987-12-31
GR69231B (fr) 1982-05-10
AT373884B (de) 1984-02-27
FI69456B (fi) 1985-10-31
IT1120443B (it) 1986-03-26
FI792006A (fi) 1979-12-28
DD144542A5 (de) 1980-10-22
ES481917A1 (es) 1980-02-16
SE7905608L (sv) 1979-12-28

Similar Documents

Publication Publication Date Title
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO784397L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater
NO151966C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazol-5-eddiksyrederivater
NO800858L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO792829L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater
NO803136L (no) Fremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater
NO152935C (no) Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater.
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO151546C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoner
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO147560C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO151201C (no) Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater
NO151500C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater
NO152005C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyrederivater
NO152255C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO145236C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive omega-aminocarboxylsyrederivater
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO152089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO146356C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater